Innovation Incentives in the Pharmaceutical Sector: Re-thinking Competition and Public Policy?

2021 ◽  
Author(s):  
Frank P. Maier-Rigaud ◽  
Robert Lauer ◽  
Laura Robles
Keyword(s):  
Public Policy ◽  
Pharmaceutical Sector ◽  
Innovation Incentives

scholarly journals Public policy of GST in India: A study on pharmaceutical sector with special reference to Healthcare

2019 ◽  
Vol 10 (4) ◽  
pp. 3136-3142
Author(s):  
Arun Gautam ◽  
Shivani Kampani ◽  
Gaurav Lodha ◽  
Vadera M L
Keyword(s):  
Public Policy ◽  
Special Reference ◽  
Precious Metals ◽  
Practical Reasons ◽  
Pharmaceutical Sector ◽  
Special Rate

India's greatest duty move is now a reality. 1999 was the year when GST was thought of. The amending bill for the full-powered launch of GST was approved by the Rajya Sabha on 8 August 2016, and it was enacted in late August. It is essential to comprehend that GST isn't a duty concession scheme where every good and service has become way cheaper just because the administration has decreased the duty rates. The single Revenue Neutral Rate (RNR) was a difficult system to manage, and thus the Indian govt. I wanted to fix it. Nonetheless, because of practical reasons, "four GST slabs have been set at 5%, 12%, 18%, and 28%. Precious metals have a special rate. The rate of 18% would anyway be relevant for most goods. GST was enacted on 1 July 2017."

Public Policy Agenda Adapts to Needs

ASHA Leader ◽  
2012 ◽  
Vol 17 (15) ◽  
pp. 23-23
Author(s):  
George Lyons
Keyword(s):  
Public Policy ◽  
Policy Agenda
Sign in / Sign up

Export Citation Format

Share Document